-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Distal Symmetric Polyneuropathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Distal Symmetric Polyneuropathy Drug Details: Ricolinostat (ACY-1215) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Diabetic Neuropathic Pain
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Diabetic Neuropathic Pain Drug Details: Ricolinostat (ACY-1215) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Refractory Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Refractory Multiple Myeloma Drug Details: Ricolinostat (ACY-1215) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Relapsed Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Relapsed Multiple Myeloma Drug Details: Ricolinostat (ACY-1215) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Chronic Lymphocytic Leukemia (CLL) Drug Details: Ricolinostat (ACY-1215) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Chemotherapy Induced Peripheral Neuropathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Chemotherapy Induced Peripheral Neuropathy Drug Details: Ricolinostat (ACY-1215) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Charcot-Marie-Tooth Disease Type II
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Charcot-Marie-Tooth Disease Type II Drug Details: Ricolinostat (ACY-1215) is under development for the...
-
Product Insights
![]()
France Gov/ ITER Org – Cadarache ITER Nuclear Fusion Power Plant 500 MW – Provence-Alpes-Cote d’Azur
Equip yourself with the essential tools needed to make informed and profitable decisions with our France Gov/ ITER Org - Cadarache ITER Nuclear Fusion Power Plant 500 MW - Provence-Alpes-Cote d'Azur report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Product Insights
![]()
Iterative Scopes Inc Pipeline Insight and Competitive Landscape, 2023
Iterative Scopes Incis a gastroenterology AI company that helps doctors by applying computer vision analytics to complex endoscopy problems. It is headquartered in Boston, Massachusetts, the US. GlobalData's Medical Devices company profile report, “Iterative Scopes Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related to: Top level information about the company performance and their pipeline products Review details of major...
-
Product Insights
![]()
Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Computed Tomography Systems Pipeline Market Report Overview Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. It is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with a high risk of heart disease. It can also be used to image complex fractures, detect infarction, tumors, calcifications, hemorrhage, bone trauma, and also acute and chronic changes in...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.